Login / Signup

Randomised clinical trial: comparison of tegoprazan and placebo in non-erosive reflux disease.

Seung Han KimKwang Bum ChoHoon Jai ChunSang Woo LeeJoong Goo KwonDong Ho LeeSang Gyun KimHwoon Yong JungJi Won KimJoon Seong LeeHyojin ParkSuck Chei ChoiSam Ryong JeeHyun-Soo KimKwang Hyun KoSeun Ja ParkYong Chan LeeSoo-Heon ParkAh Rong KimEun Ji KimHyun Wook ParkBong Tae KimGeun Seog Song
Published in: Alimentary pharmacology & therapeutics (2021)
Tegoprazan 50 and 100 mg showed superior therapeutic efficacy compared with the placebo, as well as a favourable safety profile in patients with NERD. Registration number: ClinicalTrials.gov identifier NCT02556021.
Keyphrases
  • double blind
  • clinical trial
  • phase iii
  • placebo controlled
  • open label
  • phase ii
  • study protocol
  • clinical evaluation